← Back to patent-cliff list
RSS-0343
Tier C — Watch / tradeRSS-0343
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CTSC
Indications (approved)：Chronic obstructive pulmonary disease, Bronchiectasis, Asthma, Sinusitis
Regional status
US
-
EU
-
China
Phase II
2025-01-22
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of RSS-0343?
Approved indications include: Chronic obstructive pulmonary disease, Bronchiectasis, Asthma, Sinusitis.
When does the RSS-0343 patent expire?
No public expiry year is available for RSS-0343 yet; this page updates once verified.
How do I get a quote for RSS-0343 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01